Wilmington PharmaTech plans to hire 139 new employees and spend $18 million on a new research and manufacturing facility, to be located on 2309 Sunset Lake Road (Route 72) south of Newark.
The company presented plans for the project at the DelawareCouncil and Development Finance. PharmaTech is applying for $300,400 performance-based grant to support new jobs and a grant of $360,000 for assistance with capital costs.
Wilmington PharmaTech is a contract research/manufacturing organization that provides integrated services to pharmaceutical companies and biotech firms to expedite new pharmaceutical product development.
One of its offerings is the manufacturing of Active Pharmaceutical Ingredients (API’s) and related materials, an important aspect in the drug development process that is required to ensure product quality and provide consistency during formulation and manufacture, a release stated.
PharmaTech currently employs 37 full-time staff in the United States in Newark area locations including a 16,000 square foot building at 229A Lake Drive (Glasgow), a 50,000 square foot facility on Sunset Lake Road (Bear) (previously owned by DuPont) and a 40,000 square foot building at Pencader Drive (Glasgow).
“This marks the next wave of growth, positioning Wilmington PharmaTech as the leader in new drug manufacturing in the US,” Said Hui-Yin Harry Li, Ph.D., CEO of Wilmington PharmaTech. “This expansion scales up operations and significantly enhances offerings to our clients in API manufacturing and related services. It also expands our portfolio of research, development, and potential commercial API services. PharmaTech’s expansion plans fulfill the commitment to growth and its hallmark reputation for excellence for our employees, customers, partners and our community in the state of Delaware.”
Assisting Wilmington PharmaTech was the Delaware Prosperity Partnership, a public-private economic organization that was formed during a restructuring of the Delaware Economic Development Office.
To learn more about Wilmington PharmaTech, please visit http://www.wilmingtonpharmatech.com/.